FDA Drug Recalls

Recalls / Class II

Class IID-1076-2014

Product

Dr. Sheffield Triple Antibiotic Ointment, OTC a) 0.33 oz (9g) (NDC 11527-162-47); b) 1 oz (22g) (NDC 11527-163-55) SHEFFIELD PHARMACEUTICALS, New London, CT 06320

Brand name
Sheffield Triple Antibiotic
Generic name
Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate
Active ingredients
Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate
Route
Topical
NDC
11527-162
FDA application
M004
Affected lot / code info
20154 EXP.12/13, 20153 EXP.12/13, 20152 EXP.12/12, 20151 EXP.12/11, 20093 EXP.12/13, 20092 EXP.12/13, 20091 EXP.12/13, 20085 EXP.12/13, 20084 EXP.12/13, 20083 EXP. 2/13, 20082 EXP.12/13, 20073 EXP. 12/13, 20074 EXP. 12/13, 20075 EXP. 12/13, 20081 EXP.12/13, 20021 EXP. 12/13

Why it was recalled

Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found during environmental testing

Recalling firm

Firm
Faria Limited LLC dba Sheffield Pharmaceuticals
Manufacturer
Sheffield Pharmaceuticals LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
170 Broad St, New London, Connecticut 06320-5313

Distribution

Quantity
332508
Distribution pattern
Nationwide

Timeline

Recall initiated
2013-11-22
FDA classified
2014-02-05
Posted by FDA
2014-02-12
Terminated
2014-06-09
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1076-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.